Clinical Trial 50057

Rutland, VT 05701


The purpose of this study is to assess the efficacy of seltorexant compared with placebo as adjunctive therapy to an antidepressant in improving depressive symptoms in participants with major depressive disorder with insomnia symptoms (MDDIS) who have had an inadequate response to current antidepressant therapy with an selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI) in double-blind treatment phase and to assess the long-term safety and tolerability of seltorexant as adjunctive therapy to an antidepressant in participants with major depressive disorder (MDD) in open-label treatment phase.

  • Be 18 Years to 74 Years
  • Have been diagnosed with Depression
  • Have taken antidepressant in the past that did not work well
  • Be currently taking an antidepresant medication but still have symptoms of depression

Qualified Participants May Receive:

Study related medical care and investigational medication at not cost


Available At:

Green Mountain Research Institute
198 North Main Street
Suite 12
Rutland, VT 05701
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.